Low Dose Naltrexone (LDN) is a drug that may help regulate a dysfunctional immune system in autoimmune diseases such as Cancers, HIV/Aids, Fibromyalgia, MS, Crohn's etc. LDN can be prescribed "off-label" on the NHS and has few side effects. We strive to make LDN a first line treatment available for all on the NHS.
The LDN Research Trust was founded in 2004 in the UK, although we help people around the world. The primary aim of the Trust is to initiate Clinical Trials of Low Dose Naltrexone for Autoimmune Diseases and Cancers.
Whilst working to raise funds for trials, we have helped over 59,000 people to obtain LDN from a General Practitioner or Consultant, either through the National Health Service or by private prescription. We are proud to have helped people not just in the UK but in countries throughout Europe, as well as the USA, Canada, West Indies, Australia, New Zealand, and beyond. On this website and from our downloadable newsletters, you will be able to read the stories of some of these people.
We have helped many people with MS, Crohn's, IBS, ME and Cancer to name a few. The use of LDN is spreading.
By raising awareness of LDN and funding clinical trials that will be published for the benefit of the public, we hope to achieve our ultimate goal for everyone to be prescribed LDN on the NHS and around the world, for all conditions where LDN could be of benefit. The LDN Research Trust is a non-profit-making Registered Charity, and everyone is a volunteer. Only expenses for the running of the Charity will be taken, and these will be at cost.
To help us continue our work to bring relief to all people with Multiple Sclerosis and other conditions, we would appreciate help with fund raising, either in cash or in kind. You can be sure that all contributions are greatly appreciated, however small.
